May 2026
đź“Ł VC round data is live. Check it out!
Largest Public Companies in Ireland
Benchmark revenue and EBITDA valuation multiples for public comps like
Ryanair, Smurfit WestRock, Bank of Ireland, Kingspan Group and Kerry Group.
 | Ryanair is Europe’s largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 “Gamechanger” variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe. | $27 | +2% | $29B | $27B | 1.7x | 7.6x | ||
| Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe. | $41 | -6% | $21B | $35B | 1.1x | 7.1x | ||
| Bank of Ireland Group PLC is an Irish financial services group operating mostly in Ireland and the United Kingdom. Services include mortgages, business, and corporate lending, term loans, leasing, foreign exchange, life assurance, and pension products, among others. The bank's trading divisions include Retail Ireland, Wealth and Insurance, Retail UK, Corporate and Treasury (C&T), and Group Centre. The bank generates the majority of its revenue from Retail Ireland and serves consumer and business customers across a broad range of segments and sectors. Revenue is also derived from fees for a range of banking and transaction services. The bank has access to distribution in the United Kingdom via its relationship as a financial services partner with the nation's post office. | $20 | +42% | $19B | $31B | 6.3x | — | ||
| Kingspan is a global leader in high-performance insulation and building envelope solutions. It's been a serial acquirer of insulation companies since the 1980s and boasts a well-known brand that resonates with risk-averse project specifiers. In recent years, it has focused on expanding its product scope beyond insulation and now offers a comprehensive suite of products and solutions for the broader building envelope. Today, its insulated building envelopes segment generates 82% of group sales, while the rest comes from Advnsys. Kingspan has more than 270 manufacturing sites spread across 80 countries. It has leading positions in Europe (71% of sales) and North America (22%), and it is highly exposed to new-build (75%) and nonresidential construction (75%). | $91 | +5% | $16B | $19B | 1.7x | 12.9x | ||
| Kerry Group is a leading taste and ingredient technology company and an innovation partner for the food, beverage, and pharmaceutical sectors. The company has more than 200 locations that supply clients in more than 50 countries. Its taste and nutrition unit earns around 70% of its revenue from developed countries and 30% from the developing world, servicing a wide range of sectors, such as meat, meals, snacks, dairy, drinks, and pharmaceuticals. Kerry has expanded through a combination of organic development and dozens of tuck-in acquisitions. | $83 | -25% | $13B | $16B | 2.0x | 11.0x | ||
| Glanbia PLC is a ingredient and branded performance nutrition manufacturer company. Company offer an incredible breadth of expertise in nutrition. It works with food and beverage companies and sell the products across the globe . The company segments include Glanbia Performance Nutrition, Glanbia Nutritionals and All other segments. The company generates majority of the revenue from Glanbia Nutritional segment. | $23 | +55% | $6B | $6B | 1.5x | 11.6x | ||
| Permanent TSB Group Holdings PLC is a full-service Retail and SME bank in Ireland. The company serves individual customers and small- to medium-sized enterprises through a multi-channel distribution model. Such channels include Branch Network, Brokers, Direct, Digital, and SME. It provides mainstream transactional banking, lending, saving, and deposit-taking services. | $3 | -- | $2B | $4B | 5.6x | — | ||
| Cairn Homes PLC is an Irish homebuilder. Its core activity is to design and develop properties for residential purposes, majorly in the suburbs of Dublin City. The company's portfolio predominantly comprises single-family homes and apartments that form a minor share. Its sales of residential properties generates the majority of the company's revenue. The company has various Projects like New Homes, Buildings, Commercial and Retail, and Sven Mills. Company's business has the resources and capabilities to deliver a choice of new homes where people want to live now and into the future. Creating new communities of connection and belonging, building towards an Ireland where everyone can thrive. | $3 | -- | $2B | $2B | 1.7x | 9.4x | ||
| GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development. | $22 | +79% | $1B | $1B | — | (25.0x) | ||
| Glenveagh Properties PLC is engaged in homebuilding in Ireland. The company is organized into three key reportable segments. The Suburban segment is engaged in housing (with some low-rise apartments) with demand from private buyers and institutions. The urban segment is engaged in developing apartments to deliver to institutional investors. The apartments are located in Dublin and Cork and on sites adjacent to rail transportation hubs. The partnerships segment involves the Government, local authorities, or state agencies contributing their land on a reduced cost or phased basis into a development agreement with Glenveagh. | $3 | -- | $1B | $2B | 1.4x | 9.0x | ||
| Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain and Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. | $5 | -- | $1B | $2B | 0.5x | 11.1x | ||
| Irish Continental Group PLC is a transportation and logistics company domiciled in Ireland. The company organizes itself into two segments: ferries and containers & terminals. The ferries segment transports passengers and vehicles on roll-on/roll-off ferries and chartering vessels. The containers and terminal segment transports cargo and provides stevedoring and other related terminal services. The company derives maximum revenue from Ferries Segment. Its geographical segments are Ireland, United Kingdom, Netherlands, Belgium, France, Poland, Germany, Austria, and Others. | $8 | -- | $1B | $1B | 1.8x | 8.0x | ||
| Greencoat Renewables PLC is a sector-focused listed renewable infrastructure company, investing in renewable electricity generation assets. The Group is engaged in a single segment of business, being investment in renewable infrastructure to generate investment returns while preserving capital. The Group presents the business as a single segment comprising a homogeneous portfolio. It geographically operates in the Republic of Ireland, Germany, France, Sweden, and Spain. | $1 | +9% | $990M | $2B | 197.5x | (278.4x) | ||
| FBD Holdings PLC is a property and casualty insurer, that looks after the insurance needs of farmers, consumers, and business owners. The company operates through two segments: general insurance and other group activities. All of its operations are located in Ireland. | $19 | -- | $697M | $562M | 1.0x | — | ||
| Fineos Corp Holdings PLC is an Irish company engaged in providing software solutions that include management and administration of policies and claims to the life, accident, and health insurance industry. The company's platform, Fineos AdminSuite, comprises Fineos Absence, Fineos Billing, Fineos Claims, Fineos Payments, and Fineos Provider, among other solutions. | $2 | +20% | $680M | $649M | 4.0x | 18.0x | ||
| Origin Enterprises PLC offers comprehensive solutions for all land types, from optimizing crop fields to managing ecological landscapes and green spaces for sports and wellbeing. Its main activities include providing value-added services, technologies, and inputs to primary food producers. Operations in manufacturing, R&D, trading, distribution, and digital services span Ireland, the UK, Brazil, Poland, and Romania. The business is organized into two segments: Agriculture, serving growers and upstream firms across Ireland, the UK, Continental Europe, and Latin America; and Living Landscapes, delivering products and services for sports and environmental markets in Ireland and the UK. The majority of revenue is generated from Agriculture. | $5 | +30% | $570M | $980M | 0.4x | 6.2x | ||
| Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer’s disease (PRX123), Neurodegeneration (PRXPRX019), and Others. | $9 | +105% | $494M | $172M | 17.7x | (0.9x) | ||
| kneat.com Inc is in the business of developing and marketing a software application for modeling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed the Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance, which include product support services. The company geographically operates in North America, Europe and Asia Pacific, out of which it earns maximum revenue from North America. | $4 | -18% | $370M | $356M | 7.7x | 31.9x | ||
| Hostelworld Group PLC is a social network-powered Online Travel Agent (OTA) focused on the hostel market. It has developed and promoted the Hostelworld brand, operating a two-sided marketplace focused on the hostelling category. The Hostel partners load their bed inventory to the company's platform, which it markets to customers via its website and mobile Android and iOS apps. In addition, the Hostelworld platform has a series of social features on its platform that connect travellers in hostels and cities based on their booking data. Geographically, it derives maximum revenue from Europe, followed by Asia, Africa and Oceania, and the Americas. | $1 | -11% | $176M | $175M | 1.6x | 7.6x | ||
| Malin Corporation PLC is a life sciences company. Its investee companies are in science and discovery, clinical and commercial sectors. The company's approach is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-trade sale operating businesses in the life sciences industry. The company derives all of its revenue from its subsidiary. The company focuses on oncology, immunology, and genetic diseases where it believes that life science and healthcare technologies will deliver transformative treatments for patients. | $9 | -2% | $41M | ($32M) | — | (91.6x) | ||
| Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment. | $1 | -7% | $12M | $145M | 3.3x | (6.8x) | ||
| SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. | $9 | -100% | $3M | $310K | — | (0.0x) | ||
| Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections. | $0 | -95% | $3M | $26M | — | (1.2x) | ||
| Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally. | $0 | -- | $0K | $155M | 3.0x | (1.1x) | ||
| Median | $6 | +2% | $1B | $1B | 1.8x | 7.6x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.